Interpharma Pty Ltd v Commissioner of Patents

Link copied
Case Copied 20 min read

FEDERAL COURT OF AUSTRALIA

Interpharma Pty Ltd v Commissioner of Patents [2008] FCA 1283

TRADE PRACTICES – misleading and deceptive conduct – “in trade or commerce” – application to Commissioner of Patents for extension of patent term – application alleged to contain misleading and deceptive statements – whether statements made in trade or commerce.

ADMINISTRATIVE LAW – extension of patent term – application for review of decision to grant – standing of applicant – whether person aggrieved – delay in making application – whether disentitling.

PRACTICE AND PROCEDURE – summary judgment – application by defendant – applicable principles.

Administrative Decisions (Judicial Review) Act 1977 (Cth) ss 5, 15, 16
Judiciary Act 1903 (Cth) s 39B
Patents Act 1990 (Cth) ss 138(1), 192
Trade Practices Act 1974 (Cth) ss 52, 82, 87
Federal Court of Australia Act 1976 (Cth) s 31A

White Industries Aust Ltd v Federal Commissioner of Taxation (2007) 160 FCR 298 followed
Glueck v Stang (2008) 76 IPR 75 followed
Concrete Constructions (NSW) Pty Ltd v Nelson (1990) 169 CLR 594 applied
Village Building Co Ltd v Canberra International Airport (No 2) (2004) 134 FCR 422 cited
RGC Mineral Sands Ltd v Wimmera Industrial Minerals Pty Ltd (No 2) [2000] FCA 22 cited
Assa Abloy Australia Pty Ltd v Australian Lock Co Pty Ltd (2005) 68 IPR 105 applied
Ritz Hotel Ltd v Charles of the Ritz Ltd (1988) 15 NSWLR 158 considered
Australian Foreman Stevedores Association v Crone (1988) 20 FCR 377 followed

INTERPHARMA PTY LTD (ACN 099 877 899) v THE COMMISSIONER OF PATENTS and ELI LILLY AND COMPANY; ELI LILLY AND COMPANY and ELI LILLY AUSTRALIA PTY LTD (ACN 000 233 992); INTERPHARMA PTY LTD (ACN 099 877 899)

VID 160 OF 2008

SUNDBERG J
21 AUGUST 2008
MELBOURNE


IN THE FEDERAL COURT OF AUSTRALIA

VICTORIA DISTRICT REGISTRY

VID 160 OF 2008

BETWEEN:

INTERPHARMA PTY LTD (ACN 099 877 899)
Applicant

ELI LILLY AND COMPANY
First Cross-Claimant

ELI LILLY AUSTRALIA PTY LTD (ACN 000 233 992)
Second Cross-Claimant

AND:

THE COMMISSIONER OF PATENTS
First Respondent

ELI LILLY AND COMPANY
Second Respondent

INTERPHARMA PTY LTD (ACN 099 877 899)
Cross-Respondent

JUDGE:

SUNDBERG J

DATE OF ORDER:

21 AUGUST 2008

WHERE MADE:

MELBOURNE

THE COURT ORDERS THAT:

(1)Paragraphs 1 to 6, 8 and 10 of the Amended Application and paragraphs 7 to 19 of the Amended Statement of Claim be dismissed pursuant to s 31A of the Federal Court of Australia Act 1976 (Cth).

(2)The applicant’s motion notice of which was filed on 22 July 2008 be dismissed.

(3)The applicant pay the first respondent’s costs of the motion referred to in order 2 and of the first respondent’s motion notice of which was filed on 22 May 2008.

Note:    Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.


IN THE FEDERAL COURT OF AUSTRALIA

VICTORIA DISTRICT REGISTRY

VID 160 OF 2008

BETWEEN:

INTERPHARMA PTY LTD (ACN 099 877 899)
Applicant

ELI LILLY AND COMPANY
First Cross-Claimant

ELI LILLY AUSTRALIA PTY…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Interpharma Pty Ltd v Commissioner of Patents and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2008] FCA 1283
Decision Date

CaseChat Overview and Summary

In the Federal Court of Australia, the case of Interpharma Pty Ltd v Commissioner of Patents involved a dispute concerning the validity and extension of a patent. Interpharma Pty Ltd challenged the patent granted to Lilly, specifically focusing on the extension of the patent term. The case arose after the opposition period had expired, and an extension was granted to the patent. Interpharma argued that the extension should not be valid due to certain procedural delays and the fact that Interpharma was incorporated nearly two years after the extension was granted.

The legal issues in the case centred on whether the patent extension could be challenged years after it was granted and whether Interpharma's delay in initiating proceedings affected its ability to successfully challenge the patent. The court had to consider the public interest in the administration of the patent system and the fairness of allowing such a long delay in challenging the patent extension. The court also needed to determine if Interpharma's delay in instituting the proceeding impacted its chances of success and if the proposed amendments to the application and statement of claim should be allowed.

The court found that once the opposition period had expired and an extension was granted, both the patentee and third parties were entitled to proceed based on the extension. It was noted that the applicant's delay in instituting the proceeding was significant, with the challenge being brought nearly eight years after the grant and six years after the applicant's incorporation. The court concluded that the delay undermined any reasonable prospect of successfully prosecuting the proceedings and that the public interest in the timely administration of the patent system favoured finality. Consequently, the court dismissed the application and the proposed amendments, and ordered Interpharma to pay costs to Lilly.

Orders

Orders of the court

(1) Paragraphs 1 to 6, 8 and 10 of the Amended Application and paragraphs 7 to 19 of the Amended Statement of Claim be dismissed pursuant to s 31A of the Federal Court of Australia Act 1976 (Cth).

(2) The applicant’s motion notice of which was filed on 22 July 2008 be dismissed.

(3) The applicant pay the first respondent’s costs of the motion referred to in order 2 and of the first respondent’s motion notice of which was filed on 22 May 2008.

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

SUNDBERG J
I agree with Lilly that once the opposition period has expired and an extension is granted, the patentee and third parties are prima facie entitled to proceed on the basis of the extension. Admittedly, one must take into account that the applicant was not incorporated until nearly two years after the extension. Nevertheless, the public interest to which I have referred is relevant notwithstanding that. As a matter of fairness in the administration of the patent system, it would be extraordinary if extensions could be challenged some eight years after grant. Even taking into account the applicant’s date of incorporation, it would still be extraordinary that a challenge could be made six years after that.CONCLUSION I am satisfied that the applicant has no reasonable prospect of successfully prosecuting the ADJR, s 192 or s 39B parts of the proceeding because of its delay in instituting the proceeding. Because those parts of the proceeding will not proceed, it would be pointless to allow the amendments sought in the applicant’s notice of motion.

Ratio Decidendi

Legal Principle Established

Established by: SUNDBERG J